Transgene
TNG | PA
Overview
Corporate Details
- ISIN(s):
- FR0005175080
- LEI:
- 969500PDJW8N0FSGGK69
- Country:
- France
- Address:
- 400 BOULEVARD GONTHIER D'ANDERNACH, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.transgene.fr/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Transgene is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer. Our approach uses the mechanisms of the immune response to enable the patient’s body to fight against disease.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-22 17:45 |
Regulatory News Service
Transgene présente des données de survie sans récidive à 24 mois sur l’ensemble…
|
French | 378.1 KB | |
| 2025-05-22 17:45 |
Regulatory News Service
Transgene to Present 24-month Disease-Free Survival Data from All Patients in P…
|
English | 412.3 KB | |
| 2025-05-15 17:45 |
Inside Information Statement
Assemblée Générale Mixte de Transgene du 15 mai 2025
|
French | 315.4 KB | |
| 2025-05-15 17:45 |
Inside Information Statement
Transgene's Combined General Meeting of May 15, 2025
|
English | 285.9 KB | |
| 2025-04-24 17:45 |
Quarterly Report
Transgene Provides Business and Financial Update for Q1 2025
|
English | 310.4 KB | |
| 2025-04-24 17:45 |
Earnings Release
Transgene fait le point sur ses activités et sa situation financière au premier…
|
French | 452.4 KB | |
| 2025-04-24 08:00 |
General Meeting Notice
Mise à disposition des documents préparatoires à l'Assemblée générale du 15 mai…
|
French | 277.8 KB | |
| 2025-04-24 08:00 |
General Meeting Notice
Availability of Preparatory Documents for the Combined General Meeting of May 1…
|
English | 262.6 KB | |
| 2025-04-23 17:45 |
Regulatory News Service
Transgene communiquera, dans une présentation orale rapide, de nouvelles donnée…
|
French | 414.8 KB | |
| 2025-04-23 17:45 |
Regulatory News Service
Transgene to Provide Updated Phase I Data in a Rapid Oral Presentation on Indiv…
|
English | 369.6 KB | |
| 2025-04-10 20:15 |
Registration Form
Mise à disposition du Document d’Enregistrement Universel (DEU) 2024 de Transge…
|
French | 140.9 KB | |
| 2025-04-10 20:15 |
Report Publication Announcement
Availability of Transgene’s 2024 Universal Registration Document (URD)
|
English | 171.0 KB | |
| 2025-04-10 15:38 |
Annual Report (ESEF)
Document d'enregistrement universel 2024
|
French | 5.3 MB | |
| 2025-04-01 17:45 |
Board/Management Change
Transgene recrute une Directrice des opérations techniques (CTO) pour accélérer…
|
French | 377.5 KB | |
| 2025-04-01 17:45 |
Board/Management Change
Transgene Appoints Chief Technical Officer (CTO) to Power Future Innovations
|
English | 390.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-30 | N/A | Other | Other | 30,898,876 | 32,999,999.57 EUR |
| 2023-05-26 | N/A | Other | Buy | 29,325 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |